Company / CapEx per Share
4D Molecular Therapeutics, Inc. CapEx per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.08
FY2025
5-year range
$0.04 / $0.35
FY2021-FY2025
Trend
+28.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 6 years, ranging from $0.04 in FY2021 to $0.62 in FY2020.
Based on SEC 10-K filings.
0.08 in FY2025 with a 5-year CAGR of -33.1%.
Declined from $0.35 to $0.08 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -33.6%
- 5-Year CAGR
- -33.1%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share increased 28.5% year-over-year.
- Peak capex per share was recorded in FY2020.
- Lowest capex per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +28.5% |
| FY2024 | $0.06 | -81.8% |
| FY2023 | $0.35 | +25.1% |
| FY2022 | $0.28 | +654.3% |
| FY2021 | $0.04 | -93.9% |
| FY2020 | $0.62 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026